{"id":"https://openalex.org/W4380146458","doi":"https://doi.org/10.1158/1538-7445.am2023-nd03","title":"Abstract ND03: Discovery of ARV-766, an androgen receptor degrading PROTAC\u00ae for the treatment of men with metastatic castration resistant prostate cancer","display_name":"Abstract ND03: Discovery of ARV-766, an androgen receptor degrading PROTAC\u00ae for the treatment of men with metastatic castration resistant prostate cancer","publication_year":2023,"publication_date":"2023-05-29","ids":{"openalex":"https://openalex.org/W4380146458","doi":"https://doi.org/10.1158/1538-7445.am2023-nd03"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2023-nd03","doi":"https://doi.org/10.1158/1538-7445.am2023-nd03","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2023-nd03","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Larry Snyder","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142342","display_name":"Arvinas (United States)","ror":"https://ror.org/045jkfr03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210142342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Larry Snyder","raw_affiliation_strings":["1Arvinas, Inc., New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Arvinas, Inc., New Haven, CT;","institution_ids":["https://openalex.org/I4210142342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032282104","display_name":"S H. Lee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S H. Lee","raw_affiliation_strings":["2Prelude Therapeutics, Wilmington, DE;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Prelude Therapeutics, Wilmington, DE;","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064251798","display_name":"Taavi K. Neklesa","orcid":"https://orcid.org/0009-0004-5856-2265","observed_orcids":["https://orcid.org/0009-0004-5856-2265"]},"institutions":[{"id":"https://openalex.org/I4210142342","display_name":"Arvinas (United States)","ror":"https://ror.org/045jkfr03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210142342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T K. Neklesa","raw_affiliation_strings":["1Arvinas, Inc., New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Arvinas, Inc., New Haven, CT;","institution_ids":["https://openalex.org/I4210142342"]}]},{"author_position":"middle","author":{"id":null,"display_name":"X Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142342","display_name":"Arvinas (United States)","ror":"https://ror.org/045jkfr03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210142342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"X Chen","raw_affiliation_strings":["1Arvinas, Inc., New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Arvinas, Inc., New Haven, CT;","institution_ids":["https://openalex.org/I4210142342"]}]},{"author_position":"middle","author":{"id":null,"display_name":"H Dong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142342","display_name":"Arvinas (United States)","ror":"https://ror.org/045jkfr03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210142342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H Dong","raw_affiliation_strings":["1Arvinas, Inc., New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Arvinas, Inc., New Haven, CT;","institution_ids":["https://openalex.org/I4210142342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011926011","display_name":"Cheryl A. Ferraro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142342","display_name":"Arvinas (United States)","ror":"https://ror.org/045jkfr03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210142342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C Ferraro","raw_affiliation_strings":["1Arvinas, Inc., New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Arvinas, Inc., New Haven, CT;","institution_ids":["https://openalex.org/I4210142342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001650659","display_name":"Debbie Gordon","orcid":"https://orcid.org/0009-0006-9179-9541","observed_orcids":["https://orcid.org/0009-0006-9179-9541"]},"institutions":[{"id":"https://openalex.org/I4210142342","display_name":"Arvinas (United States)","ror":"https://ror.org/045jkfr03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210142342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D A. Gordon","raw_affiliation_strings":["1Arvinas, Inc., New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Arvinas, Inc., New Haven, CT;","institution_ids":["https://openalex.org/I4210142342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000114373","display_name":"Jennifer Macaluso","orcid":"https://orcid.org/0009-0005-3441-0395","observed_orcids":["https://orcid.org/0009-0005-3441-0395"]},"institutions":[{"id":"https://openalex.org/I4210142342","display_name":"Arvinas (United States)","ror":"https://ror.org/045jkfr03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210142342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J Macaluso","raw_affiliation_strings":["1Arvinas, Inc., New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Arvinas, Inc., New Haven, CT;","institution_ids":["https://openalex.org/I4210142342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055366079","display_name":"Jennifer Pizzano","orcid":"https://orcid.org/0009-0005-5545-3909","observed_orcids":["https://orcid.org/0009-0005-5545-3909"]},"institutions":[{"id":"https://openalex.org/I4210142342","display_name":"Arvinas (United States)","ror":"https://ror.org/045jkfr03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210142342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J Pizzano","raw_affiliation_strings":["1Arvinas, Inc., New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Arvinas, Inc., New Haven, CT;","institution_ids":["https://openalex.org/I4210142342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115594995","display_name":"Jiarui Wang","orcid":"https://orcid.org/0009-0005-9890-2698","observed_orcids":["https://orcid.org/0009-0005-9890-2698"]},"institutions":[{"id":"https://openalex.org/I4210142342","display_name":"Arvinas (United States)","ror":"https://ror.org/045jkfr03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210142342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J Wang","raw_affiliation_strings":["1Arvinas, Inc., New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Arvinas, Inc., New Haven, CT;","institution_ids":["https://openalex.org/I4210142342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000833342","display_name":"Ryan R. Willard","orcid":"https://orcid.org/0009-0009-0048-6999","observed_orcids":["https://orcid.org/0009-0009-0048-6999"]},"institutions":[{"id":"https://openalex.org/I4210142342","display_name":"Arvinas (United States)","ror":"https://ror.org/045jkfr03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210142342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R R. Willard","raw_affiliation_strings":["1Arvinas, Inc., New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Arvinas, Inc., New Haven, CT;","institution_ids":["https://openalex.org/I4210142342"]}]},{"author_position":"middle","author":{"id":null,"display_name":"N Vitale","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142342","display_name":"Arvinas (United States)","ror":"https://ror.org/045jkfr03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210142342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"N Vitale","raw_affiliation_strings":["1Arvinas, Inc., New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Arvinas, Inc., New Haven, CT;","institution_ids":["https://openalex.org/I4210142342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111754288","display_name":"R. Peck","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142342","display_name":"Arvinas (United States)","ror":"https://ror.org/045jkfr03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210142342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R Peck","raw_affiliation_strings":["1Arvinas, Inc., New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Arvinas, Inc., New Haven, CT;","institution_ids":["https://openalex.org/I4210142342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064947017","display_name":"Marcia Dougan Moore","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M D. Moore","raw_affiliation_strings":["3Cardurion Pharma, Burlington, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Cardurion Pharma, Burlington, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016866989","display_name":"Craig M. Crews","orcid":"https://orcid.org/0000-0002-8456-2005","observed_orcids":["https://orcid.org/0000-0002-8456-2005"]},"institutions":[{"id":"https://openalex.org/I4210142342","display_name":"Arvinas (United States)","ror":"https://ror.org/045jkfr03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210142342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C M. Crews","raw_affiliation_strings":["1Arvinas, Inc., New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Arvinas, Inc., New Haven, CT;","institution_ids":["https://openalex.org/I4210142342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050030250","display_name":"John G. Houston","orcid":"https://orcid.org/0009-0003-9443-8870","observed_orcids":["https://orcid.org/0009-0003-9443-8870"]},"institutions":[{"id":"https://openalex.org/I4210142342","display_name":"Arvinas (United States)","ror":"https://ror.org/045jkfr03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210142342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J Houston","raw_affiliation_strings":["1Arvinas, Inc., New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Arvinas, Inc., New Haven, CT;","institution_ids":["https://openalex.org/I4210142342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007702221","display_name":"Andrew P. A. Crew","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A P. Crew","raw_affiliation_strings":["4Siduma Therapeutics, New Haven, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Siduma Therapeutics, New Haven, CT","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039592991","display_name":"I Taylor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142342","display_name":"Arvinas (United States)","ror":"https://ror.org/045jkfr03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210142342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"I Taylor","raw_affiliation_strings":["1Arvinas, Inc., New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Arvinas, Inc., New Haven, CT;","institution_ids":["https://openalex.org/I4210142342"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":27,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"83","issue":"7_Supplement","first_page":"ND03","last_page":"ND03"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.7958999872207642,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.7958999872207642,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.20280000567436218,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/protacs","display_name":"PROTACs","score":0.8289999961853027},{"id":"https://openalex.org/keywords/androgen-receptor-degradation","display_name":"androgen receptor degradation","score":0.9200000166893005},{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.9660000205039978},{"id":"https://openalex.org/keywords/metastatic-prostate-cancer","display_name":"metastatic prostate cancer","score":0.9350000023841858},{"id":"https://openalex.org/keywords/e3-ubiquitin-ligase","display_name":"E3 ubiquitin ligase","score":0.9350000023841858},{"id":"https://openalex.org/keywords/enzalutamide-resistance","display_name":"enzalutamide resistance","score":0.9399999976158142},{"id":"https://openalex.org/keywords/vcap-xenograft","display_name":"VCaP xenograft","score":0.7609999775886536},{"id":"https://openalex.org/keywords/lncap-xenografts","display_name":"LNCaP xenografts","score":0.9559999704360962},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.8619999885559082},{"id":"https://openalex.org/keywords/androgen-receptor-antagonists","display_name":"androgen receptor antagonists","score":0.5860000252723694}],"concepts":[{"id":"https://openalex.org/C2779723316","wikidata":"https://www.wikidata.org/wiki/Q6459234","display_name":"LNCaP","level":4,"score":0.9131051301956177},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.854456901550293},{"id":"https://openalex.org/C2776551883","wikidata":"https://www.wikidata.org/wiki/Q1996756","display_name":"Enzalutamide","level":5,"score":0.7360273599624634},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.7033294439315796},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5944370031356812},{"id":"https://openalex.org/C134459356","wikidata":"https://www.wikidata.org/wiki/Q4274835","display_name":"Ubiquitin ligase","level":4,"score":0.5355477333068848},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5046323537826538},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.47162532806396484},{"id":"https://openalex.org/C2992195973","wikidata":"https://www.wikidata.org/wiki/Q33123","display_name":"Protein degradation","level":2,"score":0.44970202445983887},{"id":"https://openalex.org/C25602115","wikidata":"https://www.wikidata.org/wiki/Q407111","display_name":"Ubiquitin","level":3,"score":0.405938982963562},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34801995754241943},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.28693509101867676},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.09226766228675842},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.09021219611167908},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.06932476162910461}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2023-nd03","doi":"https://doi.org/10.1158/1538-7445.am2023-nd03","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2023-nd03","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3181847396","https://openalex.org/W2885266495","https://openalex.org/W4399394844","https://openalex.org/W2921193449","https://openalex.org/W4239095818","https://openalex.org/W2740250958","https://openalex.org/W3083736404","https://openalex.org/W2999280110","https://openalex.org/W4324136944","https://openalex.org/W2964966565"],"abstract_inverted_index":{"Abstract":[0],"Prostate":[1],"cancer":[2,9,46,121,298],"is":[3,51,168],"the":[4,14,36,92,102,111,151,209,215,227,289,303],"second":[5],"leading":[6,100],"cause":[7],"of":[8,68,104,138,212,217,230,281,291,302],"death":[10],"in":[11,13,24,118,141,192],"men":[12,218,292],"United":[15],"States.":[16],"The":[17],"androgen":[18,284],"receptor":[19,285],"(AR)":[20],"plays":[21],"critical":[22],"roles":[23],"both":[25],"early":[26],"disease":[27],"and":[28,61,94,106,171,187,195,315],"advanced":[29],"prostate":[30,45,70,120,297],"cancer.":[31],"Current":[32],"therapeutic":[33,78],"approaches":[34],"targeting":[35,83],"androgen/AR":[37],"axis":[38],"are":[39],"initially":[40],"effective,":[41],"but":[42],"castration":[43,295],"resistant":[44,296],"(CRPC)":[47],"inevitably":[48],"develops.":[49],"CRPC":[50],"linked":[52],"with":[53,132,159,175,219,226,293],"increased":[54],"AR":[55,93,105,117,152,163,174],"activity":[56],"via":[57,110],"gene":[58],"overexpression,":[59],"amplification,":[60],"gain-of-function":[62],"mutations.":[63],"To":[64],"address":[65],"these":[66],"mechanisms":[67],"AR-dependent":[69],"tumor":[71,190],"growth,":[72],"we":[73],"have":[74],"developed":[75],"a":[76,81,88,133,176],"novel":[77],"agent,":[79],"ARV-766,":[80,282],"proteolysis":[82],"chimera":[84],"(PROTAC\u00ae)":[85],"that":[86],"induces":[87],"protein-protein":[89],"interaction":[90],"between":[91],"specific":[95],"E3":[96],"ubiquitin":[97],"ligase":[98],"complexes,":[99],"to":[101,161],"ubiquitination":[103],"its":[107],"subsequent":[108],"degradation":[109,135,180],"proteasome.":[112],"In":[113,165],"vitro,":[114],"ARV-766":[115,146,167,185,213,231],"degrades":[116,173],"various":[119],"cell":[122],"lines,":[123],"including":[124,199],"those":[125],"harboring":[126],"resistance-conferring,":[127],"clinically":[128],"relevant":[129],"point":[130],"mutations,":[131],"half-maximal":[134],"concentration":[136],"(DC50)":[137],"<1":[139],"nM":[140],"wild":[142],"type":[143],"VCaP.":[144],"Importantly":[145],"also":[147],"maintains":[148],"potency":[149],"against":[150],"L702H":[153],"mutant,":[154],"which":[155],"has":[156],"been":[157],"associated":[158],"resistance":[160],"some":[162],"antagonists.":[164],"vivo,":[166],"orally":[169],"bioavailable":[170],"robustly":[172],">90%":[177],"observed":[178],"maximum":[179],"(Dmax)":[181],"at":[182],"efficacious":[183],"doses.":[184],"significantly":[186],"dose-dependently":[188],"inhibits":[189],"growth":[191],"murine":[193],"LNCaP":[194],"VCaP":[196,203],"xenograft":[197],"models,":[198],"an":[200,283],"enzalutamide-insensitive":[201],"non-castrated":[202],"model.":[204],"These":[205],"preclinical":[206],"data":[207,224],"supported":[208],"clinical":[210],"development":[211],"for":[214,288,306],"treatment":[216,290],"metastatic":[220,294],"CRPC.":[221],"Selected":[222],"pre-clinical":[223],"along":[225],"chemical":[228],"structure":[229],"will":[232],"be":[233],"presented.":[234],"Citation":[235],"Format:":[236],"Larry":[237],"Snyder,":[238],"S":[239],"H.":[240],"Lee,":[241],"T":[242],"K.":[243],"Neklesa,":[244],"X":[245],"Chen,":[246],"H":[247],"Dong,":[248],"C":[249,270],"Ferraro,":[250],"D":[251],"A.":[252],"Gordon,":[253],"J":[254,256,258,273],"Macaluso,":[255],"Pizzano,":[257],"Wang,":[259],"R":[260,265],"R.":[261],"Willard,":[262],"N":[263],"Vitale,":[264],"Peck,":[266],"M":[267],"D.":[268],"Moore,":[269],"M.":[271],"Crews,":[272],"Houston,":[274],"A":[275],"P.":[276],"Crew,":[277],"I":[278],"Taylor.":[279],"Discovery":[280],"degrading":[286],"PROTAC\u00ae":[287],"[abstract].":[299],"In:":[300],"Proceedings":[301],"American":[304],"Association":[305],"Cancer":[307,326],"Research":[308],"Annual":[309],"Meeting":[310],"2023;":[311],"Part":[312],"1":[313],"(Regular":[314],"Invited":[316],"Abstracts);":[317],"2023":[318],"Apr":[319],"14-19;":[320],"Orlando,":[321],"FL.":[322],"Philadelphia":[323],"(PA):":[324],"AACR;":[325],"Res":[327],"2023;83(7_Suppl):Abstract":[328],"nr":[329],"ND03.":[330]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":2}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2023-06-11T00:00:00"}